JOHNSON & JOHNSON is 95.2x more valuable than PTC THERAPEUTICS, INC. by market capitalization ($573.98 B vs $6.03 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PTCT | JNJ |
|---|---|---|
| Market cap | $6.03 B | $573.98 B |
| US-listed rank | #1262 | #20 |
| Revenue (latest FY) | $1.73B | $94.19B |
| Net income (latest FY) | $683.00M | $26.80B |
| Net margin | 39.5% | 28.5% |
| P/E (trailing FY) | 8.8 | 21.4 |
| SEC filings | 1,262 | 984 |
JOHNSON & JOHNSON is 95.2x more valuable than PTC THERAPEUTICS, INC. by market capitalization ($573.98 B vs $6.03 B).
In their latest fiscal years, PTC THERAPEUTICS, INC. reported $1.73B in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: PTC THERAPEUTICS, INC. and JOHNSON & JOHNSON, or browse the full rankings.